-
ALS Stem Cell Therapy Fails to Meet Trial Objective
Clinical trial results of an amyotrophic lateral sclerosis, or ALS, therapy do not show slower disease progression among patients compared to a placebo.
-
Blood Cells Transport Enzymes to Slow Cancer Spread
Researchers devised a technique that in lab mice carries immune system enzymes on red blood cells to stop the spread of cancer in the lungs.
-
Covid-19 Vaccine Shown Effective, Temperature-Stable
Interim clinical trial results show the Moderna Covid-19 vaccine prevents infection in 94 percent of cases and can stored for 30 days in normal refrigeration.
-
Infographic: U.S. Public Supports Lockdown
With Covid-19 cases in the U.S. accelerating in the past few weeks, a recent poll shows the public clearly favors a lockdown to stop the rise.
-
Tech, Genomics Companies Form DNA Storage Alliance
Four companies from the computer technology and genomics industries are starting a coalition to advance DNA as a data storage medium.
-
Start-Up Gains Drug Nanoparticle Manufacturing Tech
A new enterprise spun-off from University of Connecticut is acquiring a technology for continuous manufacturing of nanoscale drug particles.
-
Covid-19 Saliva Test Earns FDA Emergency Clearance
A test to detect Covid-19 viruses in saliva rather than nasal swabs received emergency authorization from Food and Drug Administration.
-
Gene-Editing Enzyme Start-Up Gains $65M
A new company creating engineered enzymes for genome editing therapeutics is raising $65 million in its first venture funding round.
-
Personal Cancer Vaccine Induces Tumor Shrinkage
Interim results from a clinical trial show some head and neck cancer patients receiving a personalized vaccine and immunotherapy report tumor shrinkage.
-
Coronavirus Antibody Maker Raises $80M in New Funds
A company developing synthetic antibodies to protect against a range of coronavirus infections, including Covid-19, is raising $80 million in new venture funds.